Q Line Biotech Ltd vs Royal Sense Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Royal Sense Ltd changed from 34 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Royal Sense Ltd changed from ₹ 53.9 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 4 years The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 .The Revenue of Royal Sense Ltd is ₹ 0 crore as of Dec '25 . The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 .The EBITDA of Royal Sense Ltd is ₹ 0 crore as of Dec '25 . The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 .The Net Profit of Royal Sense Ltd is ₹ 0 crore as of Dec '25 . The dividend payout of Q-Line Biotech Ltd changed from 0 % to 0 % over 5 quarters. This represents a CAGR of 0.0% The dividend payout of Royal Sense Ltd changed from 0 % to 0 % over 5 quarters. This represents a CAGR of 0.0% .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Royal Sense Ltd

Royal Sense Limited was incorporated as a Public Limited Company pursuant to a Certificate of Incorporation dated April 06, 2023, issued by the Registrar of Companies, Central Registration Centre.
Prior to the incorporation of Company, the Promoter Rishabh Arora was running the business in sole proprietorships under the name 'M/s Royal Traders, M/s PHT & M/s Anaya'. In 2015, the Company started their business under proprietorship as M/s Royal Traders; in 2018 as M/s PHT and proprietorship as M/s Anaya in 2020.
Later on, April 28, 2023, the running business of the aforesaid proprietorship concern was acquired by the Company, along with the assets and liabilities of the proprietorship concern as going concern.
The Company has absorbed the business line & distribution network of firms. 'RoyalSense' is the suppliers of high quality goods that meet international standards required for hospitals, laboratories, institutions and clinics to provide health services.

FAQs for the comparison of Q-Line Biotech Ltd and Royal Sense Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Royal Sense Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Royal Sense Ltd is 37 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Royal Sense Ltd?

The stock performance of Q-Line Biotech Ltd and Royal Sense Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Royal Sense Ltd?

As of October 24, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Royal Sense Ltd stock price is INR ₹69.95.

How do dividend payouts of Q-Line Biotech Ltd and Royal Sense Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Royal Sense Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.